Oryzon Genomics (Spain) Buy Hold or Sell Recommendation
| ORY Stock | EUR 1.89 0.08 4.06% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Oryzon Genomics SA is 'Cautious Hold'. Macroaxis provides Oryzon Genomics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ORY positions. The advice algorithm takes into account all of Oryzon Genomics' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Oryzon Genomics' buy or sell advice are summarized below:
Real Value 1.87 | Hype Value 1.89 | Market Value 1.89 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Oryzon Genomics SA given historical horizon and risk tolerance towards Oryzon Genomics. When Macroaxis issues a 'buy' or 'sell' recommendation for Oryzon Genomics SA, the advice is generated through an automated system that utilizes algorithms and statistical models.
Oryzon |
Execute Oryzon Genomics Buy or Sell Advice
The Oryzon recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Oryzon Genomics SA. Macroaxis does not own or have any residual interests in Oryzon Genomics SA or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Oryzon Genomics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Oryzon Genomics Trading Alerts and Improvement Suggestions
| Oryzon Genomics SA may become a speculative penny stock | |
| Net Loss for the year was (4.69 M) with profit before overhead, payroll, taxes, and interest of 9.87 M. | |
| Oryzon Genomics SA has accumulated about 29.11 M in cash with (3.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.76. | |
| Roughly 18.0% of the company outstanding shares are owned by corporate insiders |
Oryzon Genomics Returns Distribution Density
The distribution of Oryzon Genomics' historical returns is an attempt to chart the uncertainty of Oryzon Genomics' future price movements. The chart of the probability distribution of Oryzon Genomics daily returns describes the distribution of returns around its average expected value. We use Oryzon Genomics SA price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Oryzon Genomics returns is essential to provide solid investment advice for Oryzon Genomics.
| Mean Return | -0.0061 | Value At Risk | -3.85 | Potential Upside | 4.22 | Standard Deviation | 2.64 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Oryzon Genomics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Oryzon Genomics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Oryzon Genomics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Oryzon Genomics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Oryzon stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.03 | |
β | Beta against NYSE Composite | 0.25 | |
σ | Overall volatility | 2.69 | |
Ir | Information ratio | -0.03 |
Oryzon Genomics Volatility Alert
Oryzon Genomics SA exhibits very low volatility with skewness of 1.58 and kurtosis of 6.86. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Oryzon Genomics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Oryzon Genomics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Oryzon Genomics Fundamentals Vs Peers
Comparing Oryzon Genomics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Oryzon Genomics' direct or indirect competition across all of the common fundamentals between Oryzon Genomics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Oryzon Genomics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Oryzon Genomics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Oryzon Genomics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Oryzon Genomics to competition |
| Fundamentals | Oryzon Genomics | Peer Average |
| Return On Equity | -0.0685 | -0.31 |
| Return On Asset | -0.0419 | -0.14 |
| Profit Margin | (0.33) % | (1.27) % |
| Operating Margin | (0.72) % | (5.51) % |
| Current Valuation | 107.12 M | 16.62 B |
| Shares Outstanding | 55.56 M | 571.82 M |
| Shares Owned By Insiders | 18.04 % | 10.09 % |
| Shares Owned By Institutions | 0.72 % | 39.21 % |
| Price To Earning | (12.98) X | 28.72 X |
| Price To Book | 1.65 X | 9.51 X |
| Price To Sales | 12.17 X | 11.42 X |
| Gross Profit | 9.87 M | 27.38 B |
| EBITDA | (6.58 M) | 3.9 B |
| Net Income | (4.69 M) | 570.98 M |
| Cash And Equivalents | 29.11 M | 2.7 B |
| Cash Per Share | 0.76 X | 5.01 X |
| Total Debt | 10.35 M | 5.32 B |
| Debt To Equity | 37.10 % | 48.70 % |
| Current Ratio | 2.73 X | 2.16 X |
| Book Value Per Share | 1.35 X | 1.93 K |
| Cash Flow From Operations | (3.63 M) | 971.22 M |
| Earnings Per Share | (0.09) X | 3.12 X |
| Target Price | 7.77 | |
| Number Of Employees | 43 | 18.84 K |
| Beta | 1.02 | -0.15 |
| Market Capitalization | 140.29 M | 19.03 B |
| Total Asset | 95.38 M | 29.47 B |
| Z Score | 7.8 | 8.72 |
| Net Asset | 95.38 M |
Oryzon Genomics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Oryzon . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Oryzon Genomics Buy or Sell Advice
When is the right time to buy or sell Oryzon Genomics SA? Buying financial instruments such as Oryzon Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Oryzon Genomics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Alcohol Thematic Idea Now
Alcohol
Companies involved in production and distribution of wines and alcoholic beverages. The Alcohol theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Alcohol Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Oryzon Genomics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Complementary Tools for Oryzon Stock analysis
When running Oryzon Genomics' price analysis, check to measure Oryzon Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oryzon Genomics is operating at the current time. Most of Oryzon Genomics' value examination focuses on studying past and present price action to predict the probability of Oryzon Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oryzon Genomics' price. Additionally, you may evaluate how the addition of Oryzon Genomics to your portfolios can decrease your overall portfolio volatility.
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |